SCHEMBL4904036

SCHEMBL4904036

CCN(c1nc(-c2ccc(Cl)cc2)sc1C)S(=O)(=O)c1ccc(Cl)c(C(=O)OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.54
TSHR P16473 2/20 0.54
LMNA P02545 6/20 0.42
MAPT P10636 9/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.39
HTT P42858 2/20 0.39
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
GAA P10253 2/20 0.38
NPC1 O15118 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906767 0.93 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4906041 0.92 ALDH1A1 (0.52) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4895731 0.92 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4906349 0.91 ALDH1A1 (0.50) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4904159 0.90 MEN1 (0.52) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4905738 0.90 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4901291 0.88 ALDH1A1 (0.39) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4905782 0.86 ALDH1A1 (0.44) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4901395 0.85 ALDH1A1 (0.43) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4898098 0.85 ALDH1A1 (0.41) ALDH1A1TSHRLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885LMNA 317/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.